Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Sequenom Sells Bioscience Business to Agena

Published: Friday, May 30, 2014
Last Updated: Monday, June 02, 2014
Bookmark and Share
Sequenom, Inc completes the sale of its Bioscience business to Agena Bioscience, a portfolio company of Telegraph Hill Partners.

The terms of the agreement provide for a purchase price of $31.8 million, subject to certain adjustments, and Sequenom may also receive up to $4 million in contingent consideration upon the achievement of certain regulatory and sales milestones. Agena Bioscience also assumed certain liabilities related to the Bioscience business, which does not include any portion of Sequenom's bank debt or convertible notes outstanding. The facility lease for its Bioscience location in San Diego was also assumed by Agena Bioscience. All of the current Bioscience employees will be offered employment by Agena Bioscience. 

"We are pleased to sell the business to Agena Bioscience and Telegraph Hill Partners as they plan to invest in the growth of the Bioscience business to achieve its full potential. This sale strengthens our balance sheet, and will enable us to focus exclusively on our Sequenom Laboratories business as we work toward achieving profitability," said Harry F. Hixson, Jr., Chairman and CEO of Sequenom. 

The acquired business will continue to manufacture and sell the MassARRAY® System, a proprietary mass spectrometry-based genetic analysis instrument and associated products and services that provide research and clinical investigators with economical high multiplexing, high volume results, and precise quantification in a well-established platform technology. 


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Sequenom Forms In-Network Contracts
Sequenom has formed in-network contracts with Anthem Blue Cross and Blue Shield Plans for Georgia, Indiana, Kentucky, Missouri, Ohio, Virginia and Wisconsin
Wednesday, May 04, 2016
Sequenom, Seoul National University Hospital Collaborate
Company expands clinical collaborations with leading cancer center in Asia.
Tuesday, October 06, 2015
Sequenom Announces Launch of SensiGene Fetal(XY) - Fetal Sex Determination Test
This is the company's second laboratory developed test powered by its SEQureDx™ technology.
Wednesday, February 17, 2010
Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test
Agreement covers extensive IP rights for AMD-related genetic variants that have been confirmed in multiple clinical studies around the world.
Wednesday, February 10, 2010
University of Michigan Study Shows SEQUENOM's MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test
New Study Uncovers Significant Proportion of Potential False Negatives in Widely Used HPV DNA Test which could lead to Cervical Cancer
Tuesday, July 14, 2009
SEQUENOM Announces Cost Cutting Initiative in Genetic Analysis Business
Company implements cost cutting initiatives to ensure the GA unit remains financially strong and approaches cash flow break-even.
Monday, April 27, 2009
Sequenom Selects PDI to Provide Sales Team for Launch of Noninvasive Prenatal Screening Tests
PDI to support the commercialization of SCMM's fetal Rhesus D genotyping test from a maternal blood sample.
Wednesday, March 04, 2009
Sequenom Announces Findings on Methylation Markers and RNA-SNP Markers
Company provides additional details on SEQureDx Trisomy 21 technology performance data.
Wednesday, February 04, 2009
Sequenom Announces Positive Data on Down Syndrome Detection and Unveils DNA Approach to Prenatal Diagnostics
Data continue to support market potential for Sequenom prenatal franchise; Down syndrome test on track for launch in June 2009.
Monday, February 02, 2009
Sequenom Announces Exclusive Licensing Agreement with Xenomics for Noninvasive Prenatal Diagnostics Using Transrenal DNA
Sequenom, Inc. announced that it has licensed from Xenomics, Inc. exclusive rights to patents (U.S. Patents 6,251,638 and RE 39,920, European Patent EP 0920539) for prenatal research and diagnostic products developed using fetal nucleic acids found in maternal urine.
Thursday, October 30, 2008
Sequenom Announces Licensing Agreement with Genomic Nanosystems
The license provides Sequenom with the exclusive right to use digital PCR methods for noninvasive prenatal diagnostics and analysis.
Tuesday, September 23, 2008
Sequenom Acquires License to Digital PCR and Other Noninvasive Prenatal Diagnostic Intellectual Property
The license expands Sequenom's IP portfolio of noninvasive prenatal diagnostic methods using fetal nucleic acids obtained from a maternal sample.
Wednesday, September 17, 2008
Sequenom Announces Results of Screening Studies for Down Syndrome
Company announces positive results from screening studies using the its noninvasive circulating cell-free fetal nucleic acid SEQureDx™ Technology.
Monday, June 09, 2008
Sequenom Announces Multiple MassARRAY Systems Sales in China
Beijing Genomics Institute which plans to use the MassARRAY system for its advanced research in viral genetics and human genetic projects.
Thursday, March 20, 2008
Sequenom Announces Multiple MassARRAY Systems Sales in China
Sequenom, Inc. has announced the sales of multiple MassARRAY(R) systems in China.
Wednesday, March 12, 2008
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Researchers Find a Gap in the Brain’s Firewall Against Parkinson’s Disease
Researchers at NIH have found mouse study that identified a key player in the progression of the disorder.
Fat Cells That Amplify Nerve Signals in Response to Cold Also Affect Blood Sugar Metabolism
Researchers at UTSW have found that the protein connexin 43 forms cell-to-cell communication channels on the surface of emerging beige fat cells that amplify the signals from those few nerve fibers.
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
C Dots Show Powerful Tumor Killing Effect
Nanoparticles known as Cornell dots, or C dots, have shown great promise as a therapeutic tool in the detection and treatment of cancer.
Faecal Bacteria Linked to Body Fat
Researchers at King’s College London have found a new link between the diversity of bacteria in human poo – known as the human faecal microbiome - and levels of abdominal body fat.
How Baby’s Genes Influence Birth Weight And Later Life Disease
The large-scale study could help to target new ways of preventing and treating these diseases.
Genes Underlying Dogs’ Social Ability Revealed
The social ability of dogs is affected by genes that also seem to influence human behaviour, according to a new study from Linköping University in Sweden.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!